BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22665267)

  • 1. Dysfunction of nucleus accumbens-1 activates cellular senescence and inhibits tumor cell proliferation and oncogenesis.
    Zhang Y; Cheng Y; Ren X; Hori T; Huber-Keener KJ; Zhang L; Yap KL; Liu D; Shantz L; Qin ZH; Zhang S; Wang J; Wang HG; Shih IeM; Yang JM
    Cancer Res; 2012 Aug; 72(16):4262-75. PubMed ID: 22665267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nac1 interacts with the POZ-domain transcription factor, Miz1.
    Stead MA; Wright SC
    Biosci Rep; 2014 Jun; 34(3):. PubMed ID: 24702277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleus accumbens-associated protein-1 promotes glycolysis and survival of hypoxic tumor cells via the HDAC4-HIF-1α axis.
    Zhang Y; Ren YJ; Guo LC; Ji C; Hu J; Zhang HH; Xu QH; Zhu WD; Ming ZJ; Yuan YS; Ren X; Song J; Yang JM
    Oncogene; 2017 Jul; 36(29):4171-4181. PubMed ID: 28319066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NAC1 modulates sensitivity of ovarian cancer cells to cisplatin by altering the HMGB1-mediated autophagic response.
    Zhang Y; Cheng Y; Ren X; Zhang L; Yap KL; Wu H; Patel R; Liu D; Qin ZH; Shih IM; Yang JM
    Oncogene; 2012 Feb; 31(8):1055-64. PubMed ID: 21743489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological role and prognostic significance of NAC1 in ovarian cancer.
    Nakayama K; Rahman MT; Rahman M; Yeasmin S; Ishikawa M; Katagiri A; Iida K; Nakayama N; Miyazaki K
    Gynecol Oncol; 2010 Dec; 119(3):469-78. PubMed ID: 20869761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological and clinical significance of NAC1 expression in cervical carcinomas: a comparative study between squamous cell carcinomas and adenocarcinomas/adenosquamous carcinomas.
    Yeasmin S; Nakayama K; Rahman MT; Rahman M; Ishikawa M; Katagiri A; Iida K; Nakayama N; Otuski Y; Kobayashi H; Nakayama S; Miyazaki K
    Hum Pathol; 2012 Apr; 43(4):506-19. PubMed ID: 21889186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NAC1 attenuates BCL6 negative autoregulation and functions as a BCL6 coactivator of FOXQ1 transcription in cancer cells.
    Gao M; Herlinger AL; Wu R; Wang TL; Shih IM; Kong B; Rangel LBA; Yang JM
    Aging (Albany NY); 2020 May; 12(10):9275-9291. PubMed ID: 32412910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TAp63 induces senescence and suppresses tumorigenesis in vivo.
    Guo X; Keyes WM; Papazoglu C; Zuber J; Li W; Lowe SW; Vogel H; Mills AA
    Nat Cell Biol; 2009 Dec; 11(12):1451-7. PubMed ID: 19898465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleus accumbens-1/GADD45GIP1 axis mediates cisplatin resistance through cellular senescence in ovarian cancer.
    Nakayama K; Rahman M; Rahman MT; Nakamura K; Sato E; Katagiri H; Ishibashi T; Ishikawa M; Iida K; Razia S; Ishikawa N; Kyo S
    Oncol Lett; 2017 Jun; 13(6):4713-4719. PubMed ID: 28599472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleus Accumbens 1, a Pox virus and Zinc finger/Bric-a-brac Tramtrack Broad protein binds to TAR DNA-binding protein 43 and has a potential role in Amyotrophic Lateral Sclerosis.
    Scofield MD; Korutla L; Jackson TG; Kalivas PW; Mackler SA
    Neuroscience; 2012 Dec; 227():44-54. PubMed ID: 23022214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 58-kDa microspherule protein (MSP58) is novel Brahma-related gene 1 (BRG1)-associated protein that modulates p53/p21 senescence pathway.
    Hsu CC; Lee YC; Yeh SH; Chen CH; Wu CC; Wang TY; Chen YN; Hung LY; Liu YW; Chen HK; Hsiao YT; Wang WS; Tsou JH; Tsou YH; Wu MH; Chang WC; Lin DY
    J Biol Chem; 2012 Jun; 287(27):22533-48. PubMed ID: 22563078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NAC1, a POZ/BTB protein that functions as a corepressor.
    Korutla L; Wang P; Jackson TG; Mackler SA
    Neurochem Int; 2009; 54(3-4):245-52. PubMed ID: 19121354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NAC1, a BTB/POZ protein overexpressed in uterine sarcomas.
    Rahman MT; Nakayama K; Ishikawa M; Rahman M; Katagiri H; Katagiri A; Ishibashi T; Iida K; Yamada T; Miyazaki K
    Anticancer Res; 2012 Sep; 32(9):3841-5. PubMed ID: 22993327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell cycle-dependent alteration in NAC1 nuclear body dynamics and morphology.
    Wu PH; Hung SH; Ren T; Shih IeM; Tseng Y
    Phys Biol; 2011 Feb; 8(1):015005. PubMed ID: 21301057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus oncoprotein E7 targets the promyelocytic leukemia protein and circumvents cellular senescence via the Rb and p53 tumor suppressor pathways.
    Bischof O; Nacerddine K; Dejean A
    Mol Cell Biol; 2005 Feb; 25(3):1013-24. PubMed ID: 15657429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein complex formation and intranuclear dynamics of NAC1 in cancer cells.
    Nakayama N; Kato H; Sakashita G; Nariai Y; Nakayama K; Kyo S; Urano T
    Arch Biochem Biophys; 2016 Sep; 606():10-5. PubMed ID: 27424155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ing1 mediates p53 accumulation and chromatin modification in response to oncogenic stress.
    Abad M; Menéndez C; Füchtbauer A; Serrano M; Füchtbauer EM; Palmero I
    J Biol Chem; 2007 Oct; 282(42):31060-7. PubMed ID: 17693408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient depletion of p53 followed by transduction of c-Myc and K-Ras converts ovarian stem-like cells into tumor-initiating cells.
    Motohara T; Masuko S; Ishimoto T; Yae T; Onishi N; Muraguchi T; Hirao A; Matsuzaki Y; Tashiro H; Katabuchi H; Saya H; Nagano O
    Carcinogenesis; 2011 Nov; 32(11):1597-606. PubMed ID: 21828057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of BRG1 induces CRC cell senescence by regulating p53/p21 pathway.
    Wang G; Fu Y; Hu F; Lan J; Xu F; Yang X; Luo X; Wang J; Hu J
    Cell Death Dis; 2017 Feb; 8(2):e2607. PubMed ID: 28182012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatty acid synthase expression associated with NAC1 is a potential therapeutic target in ovarian clear cell carcinomas.
    Rahman MT; Nakayama K; Rahman M; Katagiri H; Katagiri A; Ishibashi T; Ishikawa M; Iida K; Nakayama N; Otsuki Y; Nakayama S; Miyazaki K
    Br J Cancer; 2012 Jul; 107(2):300-7. PubMed ID: 22653145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.